The Vaccine News That Really Matters
Before COVID-19 upended our lives, clinical vaccine trials typically made news only when they were done—when scientists could definitively say, Yes, this one works or No, it doesn’t. These days, every step of the COVID-19 vaccine-development process comes under intense public scrutiny: This vaccine works in monkeys! It’s safe in the 45 people who have gotten it! The entire trial is on pause because one participant got sick, but we don’t know yet whether the person got a vaccine or a placebo!
“Never before have there been vaccine trials that have been followed so closely from inception to onset to conduct,” Dan Barouch, a vaccine researcher at Harvard and collaborator on Johnson & Johnson’s vaccine, says. Over the next few months, the companies behind the leading vaccine candidates will start releasing the first data from large clinical trials. Most likely, they will not be unalloyed good news or
You’re reading a preview, subscribe to read more.
Start your free 30 days